<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02261987</url>
  </required_header>
  <id_info>
    <org_study_id>FR_FQ- 013</org_study_id>
    <nct_id>NCT02261987</nct_id>
  </id_info>
  <brief_title>Resistive Inspiratory Manoeuvre as Airway Clearance Technique in Cystic Fibrosis</brief_title>
  <official_title>Role of Resistive Inspiratory Manoeuvres During Bronchial Drainage Session in Cystic Fibrosis: a Randomized Crossover Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad San Jorge</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cystic Fibrosis Foundation Therapeutics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad San Jorge</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial aims to analyze whether the resistive inspiratory manoeuvre (RIM) performed
      previously to autogenic drainage (AD) technique improves the effectiveness in terms of mucus
      clearance during a typical bronchial drainage session in adults, stable CF patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a multicenter study. 4 different Spain Cystic Fibrosis Foundations are included in the
      study (Madrid, Valencia, Murcia and Aragón). All patients will perform three different arms
      of treatment in a crossover randomization. Each arm of treatment will be apply only in one
      session. The wash-out period will be one week. Before starting the trial, all patients will
      perform a control session without any intervention, only the outcome measures will be assess.

      During the study period the patients' pharmacological treatment remained unchanged
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wet sputum production</measure>
    <time_frame>24 hours</time_frame>
    <description>24h wet sputum production (g) after bronchial drainage session</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wet sputum production</measure>
    <time_frame>30 minutes</time_frame>
    <description>Wet sputum production (g) during bronchial drainage session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Computerized respiratory sounds</measure>
    <time_frame>30 minutes</time_frame>
    <description>Adventitous respiratory sounds: crackles and wheezes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung function (simply spirometry)</measure>
    <time_frame>30 minutes</time_frame>
    <description>Forced expiratory volume at 1 second, Forced vital capacity, Forced expiratory flow 25-75</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients´ perception</measure>
    <time_frame>30 minutes</time_frame>
    <description>Visual analogical scale</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Pulse-oximetry, heart rate and dyspnea</measure>
    <time_frame>30 minutes</time_frame>
    <description>Safety and tolerability of session</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Autogenic drainage (AD)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will perform the autogenic drainage technique following the Chevallier and Agostini recommendations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistive inspiratory manoeuvre (RIM)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will perform the repetitive inspiratory manoeuvers by breathing through a fixed resistance (Power Breathe device, model KH1) . Each session will comprise to cycles of 5 inspiratory breaths (60% of maximal inspiratory pressure). Patients will be stay in both lateral decubitus position (15 min per side).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistive inspiratory manoeuvre+autogenic drainage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>First, patients will perform the resistive inspiratory manoeuvre during 10 minutes (5 min per side). Right after, patients will perform the autogenic drainage during 20 minutes.The instructions will be similar to described previously.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Autogenic drainage (AD)</intervention_name>
    <description>It will be apply in one only session. The time spent during this bronchial drainage session will be 30 minutes All patients will perform all interventions in a randomized order.</description>
    <arm_group_label>Autogenic drainage (AD)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistive inspiratory manoeuvre (RIM)</intervention_name>
    <description>It will be apply in one only session. The time spent during this bronchial drainage session will be 30 minutes All patients will perform all interventions in a randomized order.</description>
    <arm_group_label>Resistive inspiratory manoeuvre (RIM)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistive inspiratory manoeuvre+autogenic drainage</intervention_name>
    <description>It will be apply in one only session. The time spent during this bronchial drainage session will be 30 minutes All patients will perform all interventions in a randomized order.</description>
    <arm_group_label>Resistive inspiratory manoeuvre+autogenic drainage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cystic Fibrosis (CF) diagnosed ( established by genotype or sweat sodium&gt;70 mmol/l or
             sweat chloride of&gt;60 mmol/l)

          -  Clinically stable at time of study entry (defined as no requirement for antibiotics or
             change in respiratory medication in the preceding 4 wk);

          -  Chronic sputum production, at least ≥ 15 ml /24h

          -  Familiar and trained in the use of autogenic drainage technique (at least 6 months)
             and resistive inspiratory manoeuvre (at least three previous sessions)

          -  To be able to provide written, informed consent

        Exclusion Criteria:

          -  Lung function: Forced expiratory volume in 1 second &lt; 30 % pred . ; Forced vital
             capacity &lt; 40 % pred.

          -  Active haemoptysis during the previous month

          -  Supplemental oxygen or non-invasive ventilation (NIV)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beatriz Herrero, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad San Jorge</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cystic Fibrosis Association</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cystic Fibrosis Association</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cystic Fibrosis Association</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universidad San Jorge</name>
      <address>
        <city>Zaragoza</city>
        <zip>50830</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Chatham K, Ionescu AA, Nixon LS, Shale DJ. A short-term comparison of two methods of sputum expectoration in cystic fibrosis. Eur Respir J. 2004 Mar;23(3):435-9.</citation>
    <PMID>15065835</PMID>
  </results_reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2014</study_first_submitted>
  <study_first_submitted_qc>October 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2014</study_first_posted>
  <last_update_submitted>November 11, 2016</last_update_submitted>
  <last_update_submitted_qc>November 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Autogenic drainage</keyword>
  <keyword>Resistive inspiratory manoeuvre</keyword>
  <keyword>Computerized respiratory sounds</keyword>
  <keyword>Airway clearance techniques</keyword>
  <keyword>Mucus clearances</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

